Back
Taylor Devices 10K Form
Buy
59
TAYD
Taylor Devices
Last Price:
46.28
Seasonality Move:
12.67%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-03-28 | 10Q | TAYD/Taylor Devices Quarterly |
2024-01-10 | 10Q | TAYD/Taylor Devices Quarterly |
2023-09-29 | 10Q | TAYD/Taylor Devices Quarterly |
2023-03-30 | 10Q | TAYD/Taylor Devices Quarterly |
2023-01-06 | 10Q | TAYD/Taylor Devices Quarterly |
2022-09-30 | 10Q | TAYD/Taylor Devices Quarterly |
Receive TAYD News And Ratings
See the #1 stock for the next 7 days that we like better than TAYD
TAYD Financial Statistics
Sales & Book Value
Annual Sales: | $44.58M |
---|---|
Cash Flow: | $-3.84M |
Price / Cash Flow: | 29.24 |
Annual Sales: | $17.29 |
Price / Book: | 2.64 |
Profitability
EPS (TTM): | 2.90000 |
---|---|
Net Income (TTM): | $9.82M |
Gross Margin: | $20.84M |
Return on Equity: | 18.94% |
Return on Assets: | 16.28% |
Taylor Devices Earnings Forecast
Key Taylor Devices Financial Ratios
- The Gross Profit Margin over the past 37 years for TAYD is 46.74%.
- The Selling, General & Administrative Expenses for TAYD have been equal to 24.61% of Gross Profit Margin.
- The Research & Development expenses have been 0.87% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of TAYD is 20.18% of Total Revenues.
- Per Share Earnings over the last 36 years have been positive in 22 years.
Taylor Devices Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Machinery |
Sector: | Industrials |
Current Symbol: | TAYD |
CUSIP: | 877163 |
Website: | taylordevices.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 6.02 |
Quick Ratio: | 4.8 |
Price-to-Earnings
Trailing P/E Ratio: | 17.65 |
---|---|
Forward P/E Ratio: | 0 |
TAYD Technical Analysis vs Fundamental Analysis
Buy
59
Taylor Devices (TAYD)
is a Buy
Is Taylor Devices a Buy or a Sell?
-
Taylor Devices stock is rated a Buy
The current Taylor Devices [TAYD] share price is $45.54. The Score for TAYD is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.